StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
60
Publishing Date
2021 - 03 - 04
1
2020 - 11 - 23
2
2020 - 11 - 12
3
2020 - 11 - 10
1
2020 - 11 - 09
1
2020 - 11 - 05
1
2020 - 11 - 03
1
2020 - 11 - 02
1
2020 - 10 - 23
1
2020 - 10 - 21
2
2020 - 10 - 14
1
2020 - 10 - 13
1
2020 - 10 - 08
1
2020 - 10 - 06
1
2020 - 09 - 29
1
2020 - 09 - 23
1
2020 - 09 - 21
1
2020 - 09 - 14
1
2020 - 09 - 09
1
2020 - 09 - 08
1
2020 - 08 - 31
1
2020 - 08 - 24
1
2020 - 08 - 17
1
2020 - 08 - 12
1
2020 - 08 - 11
1
2020 - 08 - 07
1
2020 - 08 - 06
1
2020 - 08 - 05
2
2020 - 08 - 04
1
2020 - 08 - 03
1
2020 - 07 - 30
1
2020 - 07 - 29
2
2020 - 07 - 27
1
2020 - 07 - 23
1
2020 - 07 - 08
1
2020 - 07 - 07
1
2020 - 07 - 06
1
2020 - 06 - 30
1
2020 - 06 - 29
1
2020 - 06 - 23
2
2020 - 06 - 22
4
2020 - 06 - 12
1
2020 - 06 - 08
1
2020 - 06 - 01
2
2020 - 05 - 29
1
2020 - 05 - 27
1
2020 - 05 - 22
1
2020 - 05 - 18
1
2020 - 05 - 14
1
Sector
Electronic technology
2
Finance
12
Health technology
60
Tags
Application
4
Biopharma
1
Business contracts
1
Calendar of events
8
Cancer
6
Cardio
1
Cardiovascular
1
China
1
Collaboration
1
Commercialization
1
Company announcement
19
Conference
2
Covid
1
Cystic fibrosis
4
Directors and officers
1
Disease
2
Drug
4
Earnings releases and operating results
5
Enroll
1
Fda
3
Fda acceptance
2
Fibrosis
4
Grant
1
Granted
1
Health
3
Leukemia
1
Management statements
1
Market
1
N/a
1
Nasdaq
1
New drug
4
Nivolumab
1
Pharma
1
Phase 1
3
Phase 2
3
Phase 2b
4
Phase 3
14
Positive
2
Positive results
1
Pre-clinical
1
Preclinical
1
Presentation
3
Press releases
20
Prostate cancer
5
Research
2
Research analysis and reports
1
Results
17
Risk
1
Sclerosis
4
Therapeutics
4
Therapy
5
Topline
2
Treatment
7
Trial
3
Entities
Corbus pharmaceuticals holdings, inc.
20
Genfit s.a.
1
Morgan stanley
1
Myovant sciences ltd.
19
Onconova therapeutics, inc.
20
Symbols
CRBP
20
GNFT
1
MS
1
MYOV
19
ONTX
20
Exchanges
Nasdaq
41
Nyse
20
Crawled Date
2021 - 03 - 04
1
2020 - 12 - 01
59
Crawled Time
00:00
1940
00:20
395
01:00
1138
02:00
605
03:00
593
04:00
384
04:20
249
05:00
500
06:00
815
07:00
913
08:00
881
08:20
62
09:00
1116
10:00
1324
11:00
4436
12:00
9702
12:01
110
12:03
275
12:07
52
12:15
1012
12:20
1999
12:30
1322
13:00
7243
13:01
113
13:02
33
13:03
286
13:04
58
13:05
66
13:15
756
13:20
1484
13:30
1254
13:35
46
14:00
4863
14:01
131
14:03
80
14:15
384
14:20
856
14:30
847
15:00
2975
15:01
30
15:15
272
15:20
538
15:30
682
16:00
2217
16:01
35
16:20
490
17:00
2370
18:00
1969
19:00
1819
19:25
40
20:00
3401
20:20
296
21:00
4411
21:03
144
21:06
29
22:00
3712
22:01
87
22:15
60
22:16
37
23:00
2525
Source
www.globenewswire.com
60
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health technology
crawled time :
22:15
save search
GENFIT appoints Jean-François Tiné to the Board of Directors
Published:
2021-03-04
(Crawled : 22:15)
- globenewswire.com
GNFT
|
$3.44
-6.01%
-6.4%
2.2K
|
Health Technology
|
-29.36%
|
O:
-0.62%
H:
0.83%
C:
0.0%
Onconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
Published:
2020-05-14
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
177.78%
|
O:
11.11%
H:
0.2%
C:
-9.78%
results
Onconova Therapeutics Announces Presentation at BIO Digital 2020
Published:
2020-06-08
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
112.0%
|
O:
3.33%
H:
6.69%
C:
-0.06%
presentation
therapeutics
Onconova Therapeutics Announces Presentation at the 25th Congress of the European Hematology Association (EHA)
Published:
2020-06-12
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
67.7%
|
O:
3.97%
H:
9.68%
C:
-2.11%
Onconova Therapeutics Announces the Initiation of a Phase 1/2a Study of Rigosertib plus Nivolumab for the Treatment of KRAS+ Lung Adenocarcinoma
Published:
2020-06-22
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
72.98%
|
O:
3.79%
H:
6.33%
C:
2.38%
treatment
phase 3
phase 1
phase 2
nivolumab
Onconova Therapeutics Announces Participation in Noble Capital Markets Investor Webinar
Published:
2020-06-23
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
62.79%
|
O:
3.37%
H:
0.79%
C:
-3.97%
therapeutics
market
Onconova Therapeutics Announces Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with Azacitidine in Higher-Risk MDS
Published:
2020-07-07
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
72.86%
|
O:
-1.07%
H:
4.7%
C:
2.69%
risk
results
leukemia
research
phase 3
phase 1
phase 2
Onconova Therapeutics Announces Publication of Preclinical Data Supporting Rigosertib’s Mechanism of Action as a Targeted Anticancer Therapy
Published:
2020-07-23
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
-15.97%
|
O:
6.72%
H:
2.36%
C:
-10.24%
therapy
cancer
preclinical
pre-clinical
Onconova Therapeutics Submits Application for Rigosertib to Participate in Federally Funded Human Studies in COVID-19 Disease
Published:
2020-07-27
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
-9.91%
|
O:
12.61%
H:
0.0%
C:
-0.8%
covid
disease
application
Onconova Therapeutics Announces that the Required Number of Survival Events Has Been Reached for the Pivotal Phase 3 INSPIRE Trial Data Analysis
Published:
2020-07-29
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
-11.5%
|
O:
-1.77%
H:
24.32%
C:
15.32%
phase 3
trial
Onconova Therapeutics Announces Compliance with Nasdaq Bid Price Requirement
Published:
2020-08-04
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
-12.28%
|
O:
-2.63%
H:
2.7%
C:
-0.9%
therapeutics
nasdaq
Onconova Therapeutics to Provide Corporate Update and Second Quarter 2020 Earnings on August 12, 2020
Published:
2020-08-07
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
-6.1%
|
O:
-3.29%
H:
11.65%
C:
10.68%
Onconova Therapeutics Highlights Corporate Progress and Reports Second Quarter 2020 Financial Results
Published:
2020-08-12
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
-5.66%
|
O:
-0.94%
H:
0.0%
C:
-3.81%
results
Onconova Therapeutics Announces Topline Results from the Pivotal Phase 3 INSPIRE Trial
Published:
2020-08-24
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
-0.99%
|
O:
-72.75%
H:
44.62%
C:
24.6%
results
phase 3
trial
topline
Onconova Therapeutics Announces Election of James J. Marino, JD, MBA as Chairman of the Board of Directors
Published:
2020-08-31
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
265.23%
|
O:
0.04%
H:
0.77%
C:
-12.12%
Onconova Therapeutics Announces Participation at Upcoming Virtual Events
Published:
2020-09-09
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
382.16%
|
O:
0.0%
H:
7.52%
C:
5.01%
therapeutics
Onconova Therapeutics Announces Initiation of a Phase 1 Clinical Trial of ON 123300 in China by Partner HanX Biopharmaceuticals
Published:
2020-09-21
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
210.75%
|
O:
24.3%
H:
9.9%
C:
-9.03%
china
biopharma
trial
phase 3
phase 1
phase 2
Onconova Therapeutics to Present Update During the 2020 BIO Investor Forum Digital Event
Published:
2020-10-13
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
270.1%
|
O:
0.67%
H:
25.74%
C:
23.64%
Onconova Therapeutics to Provide Corporate Update and Third Quarter 2020 Financial Results on November 12, 2020
Published:
2020-11-05
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
290.93%
|
O:
-0.2%
H:
4.97%
C:
2.23%
results
Onconova Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
Published:
2020-11-12
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
242.7%
|
O:
-8.36%
H:
0.97%
C:
-1.08%
results
← Previous
1
2
3
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.